Product
Cytosine arabinoside
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
The Clinical Application of Tumor Reversion: A Phase I Study of Sertraline (Zoloft) in Combination With Timed-sequential Cytosine Arabinoside (Ara-C) in Adults With Relapsed and Refractory Acute Myeloid Leukemia (AML)Status: Completed, Estimated PCD: 2020-11-17